US Stock MarketDetailed Quotes

RNXT RenovoRx

Watchlist
  • 1.270
  • +0.010+0.79%
Close Nov 29 13:00 ET
  • 1.270
  • 0.0000.00%
Post 17:01 ET
30.48MMarket Cap-2189P/E (TTM)

About RenovoRx Company

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.

Company Profile

SymbolRNXT
Company NameRenovoRx
Listing DateAug 26, 2021
Issue Price9.00
Founded2012
CEOMr. Shaun R. Bagai
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address4546 El Camino Real,Suite B1
CityLos Altos
ProvinceCalifornia
CountryUnited States of America
Zip Code94022
Phone1-650-284-4433
Websitehttp://www.renovorx.com

Company Executives

  • Name
  • Position
  • Salary
  • Shaun R. Bagai
  • Chief Executive Officer and Director
  • 939.12K
  • Leesa Gentry
  • Chief Clinical Officer
  • --
  • Dr. Ramtin Agah, M.D.
  • Chief Medical Officer and Chairman of the Board
  • 507.76K
  • Ronald B. Kocak
  • Vice President, Controller and Principal Accounting Officer
  • --
  • Kirsten Angela Macfarlane
  • Independent Director
  • 82.00K
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 173.72K
  • Dr. Una S. Ryan,PhD
  • Independent Director
  • 82.00K
  • Dr. Laurence J. Marton, M.D.
  • Independent Director
  • 77.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data